Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AGC completes facility expansion for pDNA and mRNA production line
AGC Biologics has completed the facility expansion for its new plasmid DNA (pDNA) and messenger RNA (mRNA) production line at Heidelberg, Germany.
Drug Manufacturing
-
13 Oct 2023
-
06 Oct 2023
Wheeler Bio launches drug substance CGMP facility in Oklahoma City
A biomanufacturing firm Wheeler Bio has launched a drug substance current good manufacturing practices (CGMP) facility in Oklahoma City, US.
-
27 Jul 2023
Cell therapy CDMO Kincell Bio launches with $36m infusion
Kincell Bio, a cell therapy contract development and manufacturing organisation (CDMO) spun out of Inceptor Bio, has launched with $36m investment with an aim to help early-stage innovators develop and manufacture cell therapies.
-
26 Jul 2023
Biovian to expand Turku manufacturing unit with $55m investment
Contract development and manufacturing organisation (CDMO) Biovian has announced plans to make an investment worth more than $55m (€50m) to expand its manufacturing facility at Turku in Finland.
-
08 Jun 2023
Samsung Biologics, Pfizer partner for biosimilars portfolio manufacturing
Samsung Biologics has announced a strategic collaboration with Pfizer for the long-term commercial manufacturing of the latter’s multi-product biosimilars portfolio.
-
19 May 2023
NICE recommends Cara’s Kapruvia to treat CKD-associated pruritus
Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) have announced that the UK’s National Institute for Health and Care Excellence (NICE) has recommended Kapruvia (difelikefalin) to treat chronic kidney disease (CKD)-associated pruritus.
-
16 May 2023
Melinta, Xediton partner to commercialise anti-infective products in Canada
Melinta Therapeutics and Xediton Pharmaceuticals have entered an exclusive commercialisation and licensing agreement for four novel anti-infective products.
-
08 May 2023
FDA completes inspection of Nexus’ manufacturing facility in US
The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US.
-
20 Apr 2023
US FDA approves Ajinomoto Bio-Pharma’s new fill line
The US Food and Drug Administration (FDA) has granted approval for Ajinomoto Bio-Pharma Services’ high potency vial line to manufacture a commercial product.
-
13 Apr 2023
Chiesi Farmaceutici acquires biopharmaceutical firm Amryt Pharma
Chiesi Farmaceutici has completed the previously announced acquisition of global, commercial-stage biopharmaceutical company Amryt Pharma.